Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178308 · ClinicalTrials.gov registry record
Measuring Alterations of DNA in Human Blood
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 24
- Enrollment target
NCT00178308: Completed study, sponsored by University of Rochester.
NCT00178308 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178308 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate an automated, laser-based technique for measuring DNA damge resulting from radiation. We want to use controlled exposure on cancer patients to help develop a measurement to test people who may have been accidentally exposed to radiation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
What the finished NCT00178308 record still lists
NCT00178308 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00178308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00178308 about?
NCT00178308 is a clinical study titled "Measuring Alterations of DNA in Human Blood". The purpose of this research is to evaluate an automated, laser-based technique for measuring DNA damge resulting from radiation. We want to use controlled exposure on cancer patients to help develop a measurement to test people who may have been accidentally exposed to radiation.
What is the current status of trial NCT00178308?
This trial is currently completed. The enrollment target is 24 participants.
Who is sponsoring clinical trial NCT00178308?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant